We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+10.41%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$435B
AUM Growth
+$29.7B
Cap. Flow
-$2.24B
Cap. Flow %
-0.51%
Top 10 Hldgs %
21.82%
Holding
4,210
New
266
Increased
1,586
Reduced
2,101
Closed
160

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$650M
2
AAPL icon
Apple
AAPL
+$468M
3
MRVL icon
Marvell Technology
MRVL
+$458M
4
CVX icon
Chevron
CVX
+$410M
5
WIX icon
WIX.com
WIX
+$392M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$836M
2
BE icon
Bloom Energy
BE
+$727M
3
ACN icon
Accenture
ACN
+$563M
4
AVGO icon
Broadcom
AVGO
+$549M
5
LRCX icon
Lam Research
LRCX
+$543M

Sector Composition

Rank Sector Weight
1 Technology 25.76%
2 Financials 11.48%
3 Industrials 8.17%
4 Healthcare 7.37%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTD
3551
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$913M
$538K ﹤0.01%
21,683
-3,221
-13% -$78.3K
IPAC icon
3552
iShares Core MSCI Pacific ETF
IPAC
$2.66B
$534K ﹤0.01%
7,269
+985
+16% +$70.1K
STLA icon
3553
Stellantis
STLA
$16.7B
$531K ﹤0.01%
56,834
-470,587
-89% -$4.5M
PGRE
3554
DELISTED
Paramount Group
PGRE
$531K ﹤0.01%
81,122
+67,099
+478% +$446K
FTXO icon
3555
First Trust Nasdaq Bank ETF
FTXO
$305M
$529K ﹤0.01%
+14,859
New +$517K
AKRO
3556
CALL
DELISTED
Akero Therapeutics
AKRO
$527K ﹤0.01%
11,100
+300
+3% +$14.5K
GABC icon
3557
German American Bancorp
GABC
$1.91B
$525K ﹤0.01%
13,370
+371
+3% +$14.9K
XRT icon
3558
State Street SPDR S&P Retail ETF
XRT
$449M
$524K ﹤0.01%
6,083
+474
+8% +$39.5K
BBIN icon
3559
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.6B
$522K ﹤0.01%
7,410
-1,596
-18% -$109K
TARS icon
3560
Tarsus Pharmaceuticals
TARS
$2.58B
$514K ﹤0.01%
8,643
-97
-1% -$4.78K
NUMV icon
3561
Nuveen ESG Mid-Cap Value ETF
NUMV
$444M
$512K ﹤0.01%
+13,240
New +$497K
BSTZ icon
3562
BlackRock Science and Technology Term Trust
BSTZ
$1.95B
$511K ﹤0.01%
23,077
-2,308
-9% -$49.6K
LMBS icon
3563
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$511K ﹤0.01%
10,263
-340
-3% -$16.8K
FORR icon
3564
Forrester Research
FORR
$223M
$511K ﹤0.01%
48,173
-19,405
-29% -$197K
PGJ icon
3565
Invesco Golden Dragon China ETF
PGJ
$98.9M
$508K ﹤0.01%
+15,453
New +$472K
HROW icon
3566
Harrow
HROW
$1.45B
$507K ﹤0.01%
+10,525
New +$397K
CTMX icon
3567
CytomX Therapeutics
CTMX
$675M
$505K ﹤0.01%
+158,329
New +$357K
RSPG icon
3568
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$563M
$504K ﹤0.01%
6,334
-19,338
-75% -$1.48M
CGUS icon
3569
Capital Group Core Equity ETF
CGUS
$11.4B
$504K ﹤0.01%
12,753
+925
+8% +$35.5K
LE icon
3570
Lands' End
LE
$370M
$502K ﹤0.01%
35,607
-1,063
-3% -$14.2K
PWV icon
3571
Invesco Large Cap Value ETF
PWV
$1.68B
$501K ﹤0.01%
7,397
-48,766
-87% -$3.09M
NRC icon
3572
NRC Health Common Stock
NRC
$432M
$501K ﹤0.01%
39,170
-7,233
-16% -$108K
CMDT icon
3573
PIMCO Commodity Strategy Active Exchange-Traded Fund
CMDT
$803M
$499K ﹤0.01%
+18,220
New +$482K
SBR
3574
Sabine Royalty Trust
SBR
$1.06B
$499K ﹤0.01%
6,282
+66
+1% +$4.71K
VRDN icon
3575
Viridian Therapeutics
VRDN
$2.09B
$497K ﹤0.01%
23,038
-93
-0.4% -$1.68K

Similar funds

Ameriprise's Q3 2025 Portfolio in Review

As of Q3 2025, Ameriprise held 4,210 positions worth $435B, up 7.3% from $406B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ameriprise's Q3 2025 filing shows 266 new, 1,586 increased, 2,101 reduced and 160 closed positions. Its largest new stake was Aptiv: 3,450,314 shares worth $298M. The largest sale was Microsoft, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

  • Ameriprise's largest Q3 2025 buy was Aptiv: 3,450,314 shares worth $298M.
  • Ameriprise added most to Applied Materials in Q3 2025, an estimated $650M increase.
  • Ameriprise's biggest Q3 2025 reduction was Microsoft, cutting an estimated $836M.
  • Ameriprise fully exited Hess in Q3 2025, selling an estimated $77.2M.
  • Ameriprise's ten largest holdings make up 22% of its $435B portfolio in Q3 2025.
  • Ameriprise opened 266 new positions and closed 160 in Q3 2025.
  • Ameriprise's portfolio value rose 7.3% quarter-over-quarter to $435B.

Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.